146 related articles for article (PubMed ID: 15069716)
1. Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging.
Zhao JG; Feng GS; Kong XQ; Li X; Li MH; Cheng YS
World J Gastroenterol; 2004 Apr; 10(8):1152-6. PubMed ID: 15069716
[TBL] [Abstract][Full Text] [Related]
2. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging.
Chen X; Xiao E; Shu D; Yang C; Liang B; He Z; Bian D
Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):109-13. PubMed ID: 24284371
[TBL] [Abstract][Full Text] [Related]
4. Changes of tumor microcirculation after transcatheter arterial chemoembolization: first pass perfusion MR imaging and Chinese ink casting in a rabbit model.
Zhao JG; Feng GS; Kong XQ; Li X; Li MH; Cheng YS
World J Gastroenterol; 2004 May; 10(10):1415-20. PubMed ID: 15133845
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.
Larson AC; Wang D; Atassi B; Sato KT; Ryu RK; Lewandowski RJ; Nemcek AA; Mulcahy MF; Kulik LM; Miller FH; Salem R; Omary RA
Radiology; 2008 Mar; 246(3):964-71. PubMed ID: 18309018
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of microcirculation blood perfusion in patients with hepatocellular carcinoma before and after transcatheter arterial chemoembolisation using contrast-enhanced ultrasound.
Tian H; Wang Q
Eur J Cancer; 2016 Nov; 68():82-89. PubMed ID: 27728840
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
Fan WJ; Zhang L; Ouyang YS
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2474-7. PubMed ID: 19080627
[TBL] [Abstract][Full Text] [Related]
8. A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring.
Lewandowski RJ; Wang D; Gehl J; Atassi B; Ryu RK; Sato K; Nemcek AA; Miller FH; Mulcahy MF; Kulik L; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2007 Oct; 18(10):1249-57. PubMed ID: 17911515
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
Li SM; Gao ZL; Lyu XT; Jia J; Zhu P; Chen Y; Liu YL; Zhang ZX
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):429-435. PubMed ID: 30317756
[No Abstract] [Full Text] [Related]
10. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of therapeutic effectiveness of transarterial chemoembolization for hepatocellular carcinoma: correlation of dynamic susceptibility contrast-enhanced echoplanar imaging and hepatic angiography.
Tsui EY; Chan JH; Cheung YK; Cheung CC; Tsui WC; Szeto ML; Lau KW; Yuen MK; Luk SH
Clin Imaging; 2000; 24(4):210-6. PubMed ID: 11274885
[TBL] [Abstract][Full Text] [Related]
12. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
[TBL] [Abstract][Full Text] [Related]
13. MRI of hepatocellular carcinoma before and after transcatheter chemoembolization.
De Santis M; Torricelli P; Cristani A; Cioni G; Montanari N; Sardini C; Ventura E; Romagnoli R
J Comput Assist Tomogr; 1993; 17(6):901-8. PubMed ID: 8227575
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
Chen G; Ma DQ; He W; Zhang BF; Zhao LQ
World J Gastroenterol; 2008 Oct; 14(37):5738-43. PubMed ID: 18837093
[TBL] [Abstract][Full Text] [Related]
15. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.
Wu F; Wang ZB; Chen WZ; Zou JZ; Bai J; Zhu H; Li KQ; Jin CB; Xie FL; Su HB
Radiology; 2005 May; 235(2):659-67. PubMed ID: 15858105
[TBL] [Abstract][Full Text] [Related]
16. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
18. The value of paradoxical uptake of hepatocellular carcinoma on the hepatobiliary phase of gadoxetic acid-enhanced liver magnetic resonance imaging for the prediction of lipiodol uptake after transcatheter arterial chemoembolization.
Kim JW; Lee CH; Park YS; Seo TS; Song MG; Kim JH; Kim KA; Park CM
Eur J Radiol; 2017 Apr; 89():169-176. PubMed ID: 28267535
[TBL] [Abstract][Full Text] [Related]
19. Pseudolesion of the liver on gadoxetate disodium-enhanced MR images obtained after transarterial chemoembolization for hepatocellular carcinoma: clinicoradiologic correlation.
Shinagawa Y; Sakamoto K; Fujimitsu R; Shimakura M; Kora S; Takano K; Yoshimitsu K
AJR Am J Roentgenol; 2012 Nov; 199(5):1010-7. PubMed ID: 23096173
[TBL] [Abstract][Full Text] [Related]
20. Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization.
Rathmann N; Kara K; Budjan J; Henzler T; Smakic A; Schoenberg SO; Diehl SJ
Anticancer Res; 2017 Oct; 37(10):5681-5685. PubMed ID: 28982886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
